IDEAS home Printed from https://ideas.repec.org/a/dbk/procee/v1y2023ip1056294piii2023166id1056294piii2023166.html
   My bibliography  Save this article

Gliflozins, a new hope for heart failure? systematic review

Author

Listed:
  • Ana Beatriz Golin Brustolin
  • Rafael Porcile

Abstract

Heart Failure (HF) is a public health problem with high morbidity and mortality rates, as well as resource consumption. Sodium-glucose cotransporter type 2 inhibitors (SGLT-2 inhibitors), originally developed for type 2 diabetes, have become an attractive therapeutic option for HF. Recent studies have shown that gliflozins, a type of SGLT-2 inhibitor, reduce the risk of cardiovascular death and hospitalization for HF compared to placebo. Further studies are needed to confirm these findings and establish their place in the current therapy for HF. A systematic review of studies published in PUBMED evaluating the use of gliflozins, a subtype of InSGLT-2, in patients with heart failure was performed. Based on the articles analyzed, a total of 25,960 patients with heart failure were included, who were studied in 4 different studies. The use of gliflozins in patients with heart failure was found to be associated with a significant reduction in the risk of cardiovascular death, hospitalization for heart failure, and adverse cardiovascular events compared with placebo

Suggested Citation

Handle: RePEc:dbk:procee:v:1:y:2023:i::p:1056294piii2023166:id:1056294piii2023166
as

Download full text from publisher

To our knowledge, this item is not available for download. To find whether it is available, there are three options:
1. Check below whether another version of this item is available online.
2. Check on the provider's web page whether it is in fact available.
3. Perform a
for a similarly titled item that would be available.

More about this item

Statistics

Access and download statistics

Corrections

All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:dbk:procee:v:1:y:2023:i::p:1056294piii2023166:id:1056294piii2023166. See general information about how to correct material in RePEc.

If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

We have no bibliographic references for this item. You can help adding them by using this form .

If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Javier Gonzalez-Argote (email available below). General contact details of provider: https://proceedings.ageditor.ar/ .

Please note that corrections may take a couple of weeks to filter through the various RePEc services.

IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.